in focus
Proportion of deceased donors with a history of IV drug use and death due to drug overdose during 2008 and 2018 by region
Based on data from the national Organ Procurement and Transplantation Network (OPTN).
If an organ donor is an active intravenous drug user, their risk of acute hepatitis C (HCV) infection is higher than almost any other behavioral risk factor.
The increasing opiate epidemic in the U.S. has impacted every region. Because of this tragedy, more transplants, especially those from donors that could place the potential recipient at increased risk of disease transmission, are being completed.
Though there is research detailing the successful use of organs from donors who are currently using and abusing drugs, challenges remain and clinicians and patients continue to be cautious, especially regarding the risks of inadvertently acquiring viral hepatitis and/or HIV.
Fortunately, hepatitis B remains relatively uncommon in the U.S. and unanticipated HIV transmissions have not been documented since the new Public Health Service (PHS) Increased Risk Guidelines were put into place in 2013. The safety and efficacy of HCV treatments in transplant is improving day by day, but according to cases studied in 2018 by the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC), unexpected hepatitis C (HCV) donor-derived transmissions have been on the rise.
Read more about the committee’s findings and an update on its work presented at the spring 2019 regional meetings.
In focus
More than 15,000 liver transplants performed in first two years of acuity circles policy
Two-year monitoring shows many states had volume changes within 10 percent of previous policy.
7,000 organs tracked with UNOS Organ Tracking Service
30% of all OPOs use the UNOS Organ Tracking Service to monitor organs in transit.
7 years of HOPE
Implemented in 2015 , the HIV Organ Policy Equity (HOPE) Act has given more than 350 living with HIV an opportunity to receive a lifesaving transplant from an HIV-positive donor.
Over 5,000 organs tracked with UNOS Organ Tracking Service
26% of all OPOs are now utilizing the UNOS Organ Tracking Service to monitor organs in transit.
